Real-world effectiveness with the recommended single dose of respiratory syncytial virus (RSV) vaccination dipped in older ...

The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

The effectiveness of a single respiratory syncytial virus (RSV) vaccine dose declined among older adults, potentially suggesting the need for booster shots among this demographic. That is according to ...

Respiratory syncytial virus (RSV) is a common germ that can settle into your lungs and airways. It's the top cause of upper respiratory infection in babies and toddlers, but anyone can get it. While ...

As many patients and their families are learning, infection with respiratory syncytial virus (RSV) is not something to trifle with. Annually, rates of hospitalization and deaths from RSV in the U.S.

Older adults aged 75 to 79 receiving the bivalent RSV pre-F vaccine had greatly reduced hospital admission rates due to RSV-ARIs in the 2024-2025 RSV season.

The researchers found that RSV vaccination was 82.3% effective in protecting against hospital admission for participants with any RSV-associated ARI, 86.7% effective against hospital admissions for ...

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

A TODDLER was left fighting for her life after catching the ‘copycat virus’ that mimics a cold, but can be deadly. Destiny ...

Cases of RSV and flu are ticking up among young children in the U.S. even as overall respiratory virus activity remains low, ...

A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...